Equillium to Participate in Upcoming Investor Conferences
Equillium (EQ) will participate in two upcoming investor conferences in September 2026, featuring presentations and investor meetings.
Rhea-AI Summary
Equillium (EQ) will participate in two upcoming investor conferences in September 2026, featuring presentations and investor meetings.
The company will join the Cantor Global Healthcare Conference 2026 on September 9, 2026 at 9:45 AM EDT via a fireside chat and 1x1 meetings, and the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026 at 11:00 AM EDT with a company presentation and 1x1 meetings. A live webcast and 45-day replay of the Cantor fireside chat will be available through Equillium’s Investor Relations Events & Presentations page.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LA JOLLA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in the following upcoming investor conferences:
Cantor Global Healthcare Conference 2026
Format: Fireside Chat & 1x1 Meetings
Date: Wednesday, September 9, 2026
Time: 9:45 AM EDT
Webcast Link: Here
H.C. Wainwright 28th Annual Global Investment Conference
Format: Company Presentation & 1x1 Meetings
Date: Monday, September 14, 2026
Time: 11:00 AM EDT
Members of the Equillium management team will be available to meet with investors who are registered to attend the conference.
A live webcast of the Cantor fireside chat may also be accessed on the Events & Presentations page, located under the Investor Relations section on equilliumbio.com. A replay of the webcast will be available for approximately 45 days following the conference.
About Equillium
Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat severe autoimmune and inflammatory disorders.
For more information, visit www.equilliumbio.com.
Investor Contact
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com